Inventor
PANARESE JOSEPH D
US17 patents
⚠️ This page may combine multiple inventors who share the name “PANARESE JOSEPH D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
16 patentsUS11384090B2Jul 12, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC14 citations86
US11352363B1Jun 7, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC13 citations86
US11319325B1May 3, 2022
Macrocyclic spiropyrrolidine derived antiviral agents
ENANTA PHARM INC14 citations85
US11358953B2Jun 14, 2022
Functionalized peptides as antiviral agents
ENANTA PHARM INC15 citations81
US11858945B2Jan 2, 2024
Alkyne-containing antiviral agents
ENANTA PHARM INC7 citations74
US12297209B2May 13, 2025
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC0 citations62
US11952389B2Apr 9, 2024
Benzodiazepine derivatives as RSV inhibitors
ENANTA PHARM INC0 citations62
US12264159B2Apr 1, 2025
Functionalized heterocycles as antiviral agents
ENANTA PHARM INC0 citations60
US12398147B2Aug 26, 2025
Macrocyclic spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US11976084B2May 7, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US12540141B2Feb 3, 2026
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12479854B2Nov 25, 2025
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US11993600B2May 28, 2024
Saturated spirocyclics as antiviral agents
ENANTA PHARM INC0 citations51
US11802125B2Oct 31, 2023
Functionalized heterocyclic compounds as antiviral agents
ENANTA PHARM INC0 citations50
US11236108B2Feb 1, 2022
Functionalized heterocycles as antiviral agents
ENANTA PHARM INC0 citations50
US12145941B2Nov 19, 2024
Heterocyclic antiviral agents
ENANTA PHARM INC0 citations45